Usually capital initiative announcements receive a positive response, but in Lion Nathan’s case it means no acquisitions to provide ongoing growth.
Most brokers believe NAB has turned around from its dark days of forex rorts and other problems, but only ABN Amro puts it ahead of the pack.
In February 2005, Merrill Lynch downgraded Santos to Neutral. Santos has since not enjoyed one Buy rating, despite the oil price, until today – Merrills has upgraded to Buy once more.
Intersuisse doesn’t agree with ABN Amro Morgans whose analyst said earlier this week it was probably wise for investors to start taking profits on their Progen shares.
The market is worried about global inflation picking up. Some experts believe the concerns are justified.
Despite positive deal flow news, ABN Amro has lowered its recommendation on Austal to Hold, preferring a lower entry point.
ABN Amro Morgans met with the COO of life science company BRC. The broker believes the company is worth following given some positive developments.
Is Australian at risk of becoming another New Zealand? A smug Treasurer may not appreciate just what he’s done.
Ventracor has reached the milestone of 50 implants plus $60m in the bank. ABN Amro Morgans holds on to its $1.70 price target.
Unlike most leading brokerages, Intersuisse is maintaining a positive view of DCA Group.